Skip to main content

Advertisement

Table 2 Potassium values

From: Effects of 8,000 IU aXa long-term prophylaxis with certoparin on the incidence of hyperkalemia in patients with coronary heart disease – a post-hoc analysis of the PARAT trial

  Mean ± SD (mmol/l) > 5 to ≤5.5 mmol/l (%) > 5.5 mmol/l (%)*
  Certo Plac p-value** Certo Plac Certo Plac
Baseline 4.2 ± 0.4 4.2 ± 0.4 p = n.s. 3.5 0 0 0
Discharge 4.2 ± 0.4 4.2 ± 0.4 p = n.s. 3.9 4 0 0
2 weeks 4.5 ± 0.4 4.5 ± 0.4 p = n.s. 8.3 6 0 2
4-6 weeks 4.4 ± 0.4 4.4 ± 0.4 p = n.s. 8.9 4.3 0 2.2
3 months 4.4 ± 0.3 4.5 ± 0.3 p = n.s. 4.8 4.4 0 0
6 months 4.3 ± 0.3 4.3 ± 0.4 p = n.s. 4.9 2.4 0 0
  1. Legend: *there were no patients with a serum potassium > 6.0 mmol/l; **the statistical evaluation was performed using paired, two sided t-test for each of the treatment groups to compare baseline and follow-up values.